StockData
Ginkgo Bioworks Holdings, Inc. logo

Ginkgo Bioworks Holdings, Inc. (DNA) shareholders

DNANYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/3013% below fair value
$8.32−0.18 (-2.12%)

Close on Nov 17, 2026Market cap $560.27MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
53.7%
36M of 67M shares
Institutional holders
183
30 new, 19 sold out
Net institutional buying
4M
In Q2 2026
Insider trades, 12 months
0 buys · 24 sales
Net sold $4.95M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Jason Kelly85,752,3335.00%13D (active) amendmentFeb 14, 2024
Barry Canton
Joint filing with Reshma P. Shetty (9.50%)
4,716,0849.50%13D (active) amendmentFeb 14, 2025
BlackRock, Inc.4,122,5107.70%13G (passive) amendmentJun 30, 2026
Cascade Investment, L.L.C.
Joint filing with William H. Gates III (7.50%)
3,621,6367.50%13G (passive) amendmentSep 30, 2025
Viking Global Opportunities Parent GP LLC
Joint filing with Viking Global Investors LP (7.10%), Viking Global Opportunities GP LLC (7.10%) and 4 more
3,577,1287.10%13G (passive) amendmentMar 31, 2026
Austin Che2,372,5735.00%13G (passive) amendmentDec 31, 2024

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of DNAValueChange% of portfolio
BlackRock, Inc.4,282,9036.36%$42.44M+640,5560.00%
Viking Global Investors LP3,577,1285.31%$35.45M–0.10%
Erste Asset Management GmbH2,536,9393.77%$25.90M+589,2110.20%
Baillie Gifford & Co2,391,6493.55%$23.70M–0.02%
Vanguard Capital Management LLC2,087,2933.10%$20.69M+172,8650.00%
Anchorage Capital Group, L.L.C.1,746,3632.59%$17.31M–3.84%
Legal & General Group Plc1,669,4192.48%$16.54M+7,8320.00%
State Street Corp1,472,3702.19%$14.59M+125,7110.00%
Geode Capital Management, LLC1,222,0161.81%$12.11M+212,6540.00%
Forbes J M & Co Llp999,9111.48%$9.91M−28,4800.78%
Vanguard Portfolio Management LLC937,8031.39%$9.29M+372,1510.00%
Allianz Asset Management GmbH785,7981.17%$7.79M+85,2820.01%
UBS Group AG691,6591.03%$6.85M+108,8600.00%
Millennium Management LLC638,6760.95%$6.33M+150,7190.00%
Aqr Capital Management LLC621,6250.92%$6.16M+326,8370.00%
Sb Investment Advisers (Uk) Ltd610,7290.91%$6.05M–0.08%
Goldman Sachs Group Inc607,3760.90%$6.02M−322,4860.00%
Bank Of America Corp /De/545,8520.81%$5.41M+68,9390.00%
Prescott Group Capital Management, L.L.C.541,8450.80%$5.37M–0.46%
Renaissance Technologies LLC539,8560.80%$5.35M+439,4000.01%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202618336M53.7%30 / 6939 / 196M2M
Q1 202617532M48.0%30 / 5342 / 315M3M
Q4 202518133M48.5%35 / 5042 / 275M3M
Q3 202517430M45.2%31 / 4738 / 213M5M
Q2 202516633M49.6%35 / 4634 / 347M6M
Q1 202516632M47.9%31 / 4931 / 286M6M
Q4 202416633M48.3%41 / 4237 / 2410M4M
Q3 202415126M39.1%150 / 00 / 126M0M
Q2 202420M0.0%2 / 00 / 00M0M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

131 funds held DNA in Q2 2026, 66% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of DNAValue% of fundAs of
Vanguard Total Stock Market Index Fund1,489,8512.21%$14.76M0.00%Jun 30, 2026
iShares Russell 2000 ETF1,251,6731.86%$12.40M0.01%Jun 30, 2026
Vanguard Extended Market Index Fund550,0710.82%$5.45M0.01%Jun 30, 2026
Fidelity Small Cap Index Fund523,1470.78%$4.23M0.01%Jul 31, 2026
PIMCO RAE US Small Fund506,3120.75%$5.02M0.13%Jun 30, 2026
iShares Russell 2000 Value ETF446,5380.66%$4.43M0.03%Jun 30, 2026
iShares Biotechnology ETF356,2310.53%$3.53M0.04%Jun 30, 2026
ROBO Global Artificial Intelligence ETF355,1790.53%$2.87M0.69%Jul 31, 2026
State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF326,8360.49%$3.24M0.11%Jun 30, 2026
Vanguard Explorer Fund251,4370.37%$2.03M0.01%Jul 31, 2026
Vanguard Strategic Small-Cap Equity Fund234,5390.35%$2.32M0.07%Jun 30, 2026
Fidelity Extended Market Index Fund226,1380.34%$2.12M0.00%May 31, 2026
Vanguard Russell 2000 Index Fund218,2240.32%$2.04M0.01%May 31, 2026
Schwab U.S. Small-Cap ETF210,5340.31%$1.97M0.01%May 31, 2026
Invesco RAFI US 1500 Small-Mid ETF187,3140.28%$1.52M0.05%Jul 31, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Reshma P. ShettySee remarks, Director, 10% owner164,705,104244.59%Oct 21, 2026
Jason R. KellySee remarks, Director129,0650.19%Oct 21, 2026
Steven P. CoenSee remarks50,1680.07%Oct 21, 2026
Mark E. DmytrukSee remarks52,1320.08%May 22, 2025
Christian O. HenryDirector19,3100.03%Sep 16, 2026
Sri KosuriDirector24,0670.04%Jun 15, 2026
Harry SloanDirector271,4180.40%Jun 15, 2026
Ross FubiniDirector10,8220.02%Jun 15, 2026
Kathy Hopinkah HannanDirector15,0030.02%Jun 13, 2025
Shyam SankarDirector72,3720.11%Jun 13, 2025
Myrtle S. PotterDirector10,8220.02%Jun 13, 2025
Barry Canton10% owner164,705,104244.59%Oct 21, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Steven P. Coen
See remarks
Oct 19, 2026Sale−766$10.14$7.77K50,168
Barry Canton
10% owner
Oct 19, 2026Sale−22,369$10.14$226.89K453,951
Barry Canton
10% owner
Oct 19, 2026Sale−18,803$10.14$190.72K356,329
Reshma P. Shetty
See remarks, Director, 10% owner
Oct 19, 2026Sale−18,803$10.14$190.72K356,329
Reshma P. Shetty
See remarks, Director, 10% owner
Oct 19, 2026Sale−22,369$10.14$226.89K453,951
Jason R. Kelly
See remarks, Director
Oct 19, 2026Sale−45,682$10.14$463.35K129,065
Steven P. Coen
See remarks
Oct 16, 2026Option exercise+312––50,934
Steven P. Coen
See remarks
Oct 16, 2026Option exercise+1,174––50,622
Barry Canton
10% owner
Oct 16, 2026Option exercise+10,619––476,320
Barry Canton
10% owner
Oct 16, 2026Option exercise+29,279––465,701
Barry Canton
10% owner
Oct 16, 2026Option exercise+9,762––375,132
Barry Canton
10% owner
Oct 16, 2026Option exercise+26,802––365,370
Reshma P. Shetty
See remarks, Director, 10% owner
Oct 16, 2026Option exercise+9,762––375,132
Reshma P. Shetty
See remarks, Director, 10% owner
Oct 16, 2026Option exercise+26,802––365,370
Reshma P. Shetty
See remarks, Director, 10% owner
Oct 16, 2026Option exercise+10,619––476,320
Reshma P. Shetty
See remarks, Director, 10% owner
Oct 16, 2026Option exercise+29,279––465,701
Jason R. Kelly
See remarks, Director
Oct 16, 2026Option exercise+25,790––174,747
Jason R. Kelly
See remarks, Director
Oct 16, 2026Option exercise+55,694––148,957
Steven P. Coen
See remarks
Oct 5, 2026Sale(10b5-1 plan)−2,403$15.00$36.05K49,448
Christian O. Henry
Director
Sep 15, 2026Sale−5,000$7.08$35.40K19,310
Steven P. Coen
See remarks
Aug 24, 2026Sale−330$6.98$2.30K51,851
Steven P. Coen
See remarks
Aug 21, 2026Option exercise+156––52,181
Steven P. Coen
See remarks
Aug 21, 2026Option exercise+587––52,025
Steven P. Coen
See remarks
Jul 17, 2026Sale−752$7.90$5.94K51,438
Steven P. Coen
See remarks
Jul 16, 2026Option exercise+1,174––51,878
Steven P. Coen
See remarks
Jul 16, 2026Option exercise+312––52,190
Steven P. Coen
See remarks
May 22, 2026Sale−307$8.33$2.56K50,704
Steven P. Coen
See remarks
May 21, 2026Option exercise+587––50,855
Steven P. Coen
See remarks
May 21, 2026Option exercise+156––51,011
Steven P. Coen
See remarks
Apr 17, 2026Sale−324$7.95$2.58K50,268
Steven P. Coen
See remarks
Apr 16, 2026Option exercise+156––50,592
Steven P. Coen
See remarks
Apr 16, 2026Option exercise+587––50,436
Steven P. Coen
See remarks
Apr 13, 2026Sale−33,171$6.41$212.63K49,849
Steven P. Coen
See remarks
Apr 10, 2026Option exercise+28,368––37,467
Steven P. Coen
See remarks
Apr 10, 2026Option exercise+45,553––83,020
Reshma P. Shetty
See remarks, Director, 10% owner
Apr 10, 2026Sale−124,727$6.43$801.99K436,422
Barry Canton
10% owner
Apr 10, 2026Sale−124,727$6.43$801.99K436,422
Reshma P. Shetty
See remarks, Director, 10% owner
Apr 9, 2026Option exercise+251,786––561,149
Barry Canton
10% owner
Apr 9, 2026Option exercise+251,786––561,149
Jason R. Kelly
See remarks, Director
Apr 9, 2026Sale−109,767$6.40$702.51K316,483
Reshma P. Shetty
See remarks, Director, 10% owner
Apr 9, 2026Sale−13,116$6.40$83.94K338,568
Barry Canton
10% owner
Apr 9, 2026Sale−13,116$6.40$83.94K338,568
Jason R. Kelly
See remarks, Director
Apr 8, 2026Sale−97,015$6.93$672.31K426,250
Jason R. Kelly
See remarks, Director
Apr 8, 2026Option exercise+212,949––523,265
Reshma P. Shetty
See remarks, Director, 10% owner
Apr 8, 2026Sale−13,155$6.93$91.16K351,684
Reshma P. Shetty
See remarks, Director, 10% owner
Apr 8, 2026Option exercise+27,738––364,839
Barry Canton
10% owner
Apr 8, 2026Option exercise+27,738––364,839
Barry Canton
10% owner
Apr 8, 2026Sale−13,155$6.93$91.16K351,684
Jason R. Kelly
See remarks, Director
Apr 7, 2026Option exercise+212,949––310,316
Reshma P. Shetty
See remarks, Director, 10% owner
Apr 7, 2026Option exercise+27,738––337,101
Barry Canton
10% owner
Apr 7, 2026Option exercise+27,738––337,101
Steven P. Coen
See remarks
Mar 16, 2026Sale−708$6.74$4.77K9,099
Steven P. Coen
See remarks
Mar 13, 2026Option exercise+312––9,807
Steven P. Coen
See remarks
Mar 13, 2026Option exercise+1,174––9,495
Steven P. Coen
See remarks
Jan 20, 2026Sale−972$8.92$8.67K8,321
Steven P. Coen
See remarks
Jan 16, 2026Option exercise+1,062––9,293
Steven P. Coen
See remarks
Jan 16, 2026Option exercise+587––8,075
Steven P. Coen
See remarks
Jan 16, 2026Option exercise+156––8,231
Steven P. Coen
See remarks
Dec 15, 2025Sale−736$8.89$6.54K7,488
Steven P. Coen
See remarks
Dec 12, 2025Option exercise+1,174––7,912

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
14.09%
9M shares short
Days to cover
3.9
At 2M shares a day
Change since last report
+14.4%
From 8M shares
Short volume, 20 days
57.5%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Ginkgo Bioworks's stock actually held short. Settlement fails (shares not delivered on time) peaked at 18,216 shares on Oct 8, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Jason R. Kelly
Officer, Director
Oct 19, 202645,682$463.33KOct 19, 2026Restricted Stock Vesting
Steven P. Coen
Officer
Oct 19, 2026766$7.77KOct 19, 2026Restricted Stock Vesting
Barry Canton
Officer
Oct 19, 202618,803$190.71KOct 19, 2026Restricted Stock Vesting
Che Austin
Officer
Oct 19, 202616,058$162.87KOct 19, 2026Restricted Stock Vesting
Reshma P. Shetty
Officer, Director
Oct 19, 202622,369$226.88KOct 19, 2026Restricted Stock Vesting
Che Austin
Officer
Oct 19, 20262,200$22.84KOct 19, 2026Restricted Stock Vesting
Steven P. Coen
Officer
Oct 5, 20262,403$36.05KOct 5, 2026Restricted Stock Vesting
Che Austin
Officer
Sep 17, 20262,200$16.04KSep 17, 2026Restricted Stock Vesting
Christian O. Henry
Director
Sep 15, 20265,000$35.41KSep 15, 2026Restricted Stock Vesting
Steven P. Coen
Officer
Aug 24, 2026330$2.30KAug 24, 2026Restricted Stock Vesting
Che Austin
Officer
Aug 17, 20262,200$14.65KAug 17, 2026Restricted Stock Vesting
Steven P. Coen
Officer
Jul 17, 2026752$5.94KJul 17, 2026Restricted Stock Vesting
Che Austin
Officer
Jun 10, 20262,200$17.73KJun 10, 2026Restricted Stock Vesting
Steven P. Coen
Officer
May 22, 2026307$2.56KMay 22, 2026Restricted Stock Vesting
Che Austin
Officer
May 13, 20262,200$18.22KMay 13, 2026Restricted Stock Vesting

See a number that looks wrong?